Guidelines for the management of drug clinical trials during COVID-19 epidemic (on a trial basis)

China (National)

Issuing Authority: Center for Drug Evaluation, National Medical Products Administration

Type: Law/Policy Document

Issued: July 14, 2020

Download
Document

Legal Topics: Access to medicines and intellectual propertyVaccine

Tags: COVID-19-specific LawMedicines & AccessProcurement of medical supplies

More laws from China

More tagged Access to medicines and intellectual property, Vaccine

Data from China

Cumulative Cases

9,568,798

Cumulative Deaths

30,010

WHO COVID-19 Dashboard. Geneva: World Health Organization, 2020. Available online: https://covid19.who.int/ (last cited: 2022-11-25).